| Source NDC Code |
|
Target HCPCS Code |
57894-0450-01
TECVAYLI 153 MG/1.7 ML VIAL
|
⇄
|
C9148
Injection, teclistamab-cqyv, 0.5 mg
|
| Detail Information |
| Relationship Start Date |
04/01/2023 |
| Relationship End Date |
06/30/2023 |
| Number Of Items In Ndc Package |
1.7 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
57894-0450-01
TECVAYLI (PF,LATEX-FREE) 90 MG/1 ML
|
⇄
|
J9380
INJECTION, TECLISTAMAB-CQYV, 0.5 MG
|
| Detail Information |
| Relationship Start Date |
07/01/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1.7 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
SC |
| Billing Units |
ML |
|
|
|
57894-0450-01
TECVAYLI 153 MG/1.7 ML VIAL
|
⇄
|
J9999
NOT OTHERWISE CLASSIFIED, ANTINEOPLASTIC DRUGS
|
| Detail Information |
| Relationship Start Date |
04/01/2023 |
| Relationship End Date |
06/30/2023 |
| Number Of Items In Ndc Package |
1.7 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
57894-0450-01
TECVAYLI
|
⇄
|
J9380
Inj teclistamab cqyv 0.5 mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|